Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Patients Undergoing Cardiac Surgery
2017-001823-26Phase 3Terminated
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA) and cardiac morbidity (3 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Change in Echo PSSR. Started Jun 2021; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)cardiac morbidity
Beyond the preview
Go deeper on 2017-001823-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001823-26.